Celtarys Research has participated in a round table focused on new trends in oncology at Farmaforum 21
Farmaforum has become one of the most important events of the pharmaceutical industry in Spain. In the 2021 edition, it has extended its scope, sharing synergies with the biotechnology and cosmetic Industries.
On the 3rd of November, in the frame of Health&Research Forum, Celtarys Research participated in a round table entitled “New trends in Oncology: Diagnosis, Drug Discovery and Drug Delivery”. Our CEO, Sonia Martinez Arca delivered a talk about fluorescent tools for drug discovery in oncology, highlighting the application of fluorescent probes developed by Celtarys Research to identify and study different GPCRs involved in cancer. In particular, Sonia presented the interesting results obtained by the OncoMet Research group of the Health Research Institute of Santiago using Celtarys probes to analyse expression of Adenosine Receptors in cancer cells.
Other companies participating in the round table were the consortium Nasas Biotech-AMSlab, Diversa Technologies and Aptus Biotech. The discussion was moderated by Loli Pereiro and Julio Martínez from BIOGA.
Link of Interest: Farmaforum
Related posts
Discover Our New Fluorescent Ligands For Adrenergic Receptor
Celtarys Research, sponsor of the XIV Meeting of the Spanish Drug Discovery Network
New fluorescent tools to evaluate the therapeutic potential of phytocannabinoids
PERTE SALUD Proyecto Nº: IDI-2025-0751
Título: TERAPIAS AVANZADAS EN INMUNOONCOLOGÍA: UNA ESTRATEGIA INNOVADORA
BASADA EN LA DEGRADACIÓN DIRIGIDA DE GPCR EN EL EJE ADENOSINÉRGICOS
EIC Pathfinder; Project name: Unisens; Universal GPCR Activity Sensor for Next Generation Drug Discovery
Esta entidad fue beneficiaria de las ayudas para la ejecución de acciones de promoción exterior de las empresas gallegas. El objetivo principal de estas ayudas es incentivar la realización de acciones de promoción exterior generadoras de ventajas competitivas. El resultado que se pretende conseguir es el impulso de las pymes y sus productos y servicios, aumentando el número de empresas de base exportadora.
Celtarys Research is beneficiary of a WomenTechEU grant supporting deep-tech start-ups led by women
Principia 2021 Program
Celtarys staff has been funded by the Xunta de Galicia within the framework of the PRINCIPIA 2021 Program of the Galician Innovation Agency (GAIN)
InnovaPEME Program
Celtarys Innovation Plan has been funded by the InnovaPEME 2022 program of the Galician Innovation Agency (GAIN)
Bonos de Innovación de Celtarys Research (026)
Para promover o desenvolvemento tecnolóxico, a innovación e unha investigación de calidade. Esta operación está financiada pola Xunta de Galicia, a través de axudas concedidas pola Axencia Galega de Innovación, dentro do programa de axudas a empresa Bonos de innovación 2022.
Celtarys Research is part of the public-private consortium developing the project PREDICTEAM
New prognostic quantitative biomarker assays for predicting patient response to immune checkpoint inhibitor (ICI) treatment
NEOTEC · CDTI — Ministerio de Ciencia e Innovación
The Project ‘New chemical conjugation technology for therapeutic targets’ has been founded by CDTI under its program NEOTEC. The NEOTEC program objective is supporting the establishment and consolidation of technology-based enterprises. A technology-based company (EBT) is a company whose activity focuses on the exploitation of products or services that require the use of technologies and knowledge developed since the research activity. The EBT base their business strategy or activity in the intensive domain of scientific and technical knowledge. Budget awarded: 416.177€ | Execution dates: 1/1/2023 – 31/03/2024